These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10234543)

  • 1. Synthesis of cholesterol modified cationic lipids for liposomal drug delivery of antisense oligonucleotides.
    Zimmer A; Aziz SA; Gilbert M; Werner D; Noe CR
    Eur J Pharm Biopharm; 1999 Mar; 47(2):175-8. PubMed ID: 10234543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
    Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
    Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides].
    Chen HL; Liang WQ; Shao JB; Chen Z
    Yao Xue Xue Bao; 2004 Jan; 39(1):72-6. PubMed ID: 15127587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.
    Meyer O; Kirpotin D; Hong K; Sternberg B; Park JW; Woodle MC; Papahadjopoulos D
    J Biol Chem; 1998 Jun; 273(25):15621-7. PubMed ID: 9624154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.
    Junghans M; Loitsch SM; Steiniger SC; Kreuter J; Zimmer A
    Eur J Pharm Biopharm; 2005 Jul; 60(2):287-94. PubMed ID: 15939239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Pluronic on cellular uptake of cationic liposomes- mediated antisense oligonucleotides.
    Chen HL; Hu QH; Liang WQ
    Pharmazie; 2004 Feb; 59(2):131-3. PubMed ID: 15025182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells.
    Lappalainen K; Urtti A; Söderling E; Jääskeläinen I; Syrjänen K; Syrjänen S
    Biochim Biophys Acta; 1994 Dec; 1196(2):201-8. PubMed ID: 7841184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization of cationic fusogenic liposomes mediated antisense oligonucleotides into HeLa cells.
    Hu Y; Jin Y; Xia Y
    Drug Dev Ind Pharm; 2004 Feb; 30(2):135-41. PubMed ID: 15089047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes.
    Zobel HP; Werner D; Gilbert M; Noe CR; Stieneker F; Kreuter J; Zimmer A
    J Microencapsul; 1999; 16(4):501-9. PubMed ID: 10420334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides.
    Jääskeläinen I; Peltola S; Honkakoski P; Mönkkönen J; Urtti A
    Eur J Pharm Sci; 2000 May; 10(3):187-93. PubMed ID: 10767596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oligodeoxynucleotides on the physicochemical characteristics and cellular uptake of liposomes.
    Arima H; Aramaki Y; Tsuchiya S
    J Pharm Sci; 1997 Apr; 86(4):438-42. PubMed ID: 9109045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines.
    Ollikainen H; Lappalainen K; Jääskeläinen I; Syrjänen S; Pulkki K
    Leuk Lymphoma; 1996 Dec; 24(1-2):165-74. PubMed ID: 9049973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remarkable induction of apoptosis in cancer cells by a novel cationic liposome complexed with a bcl-2 antisense oligonucleotide.
    Noguchi S; Hirashima N; Furuno T; Nakanishi M
    J Control Release; 2003 Mar; 88(2):313-20. PubMed ID: 12628337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems.
    Islam A; Handley SL; Thompson KS; Akhtar S
    J Drug Target; 2000; 7(5):373-82. PubMed ID: 10721799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study.
    Lappalainen K; Miettinen R; Kellokoski J; Jääskeläinen I; Syrjänen S
    J Histochem Cytochem; 1997 Feb; 45(2):265-74. PubMed ID: 9016315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures.
    Semple SC; Klimuk SK; Harasym TO; Dos Santos N; Ansell SM; Wong KF; Maurer N; Stark H; Cullis PR; Hope MJ; Scherrer P
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):152-66. PubMed ID: 11342155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide-cationic liposome interactions. A physicochemical study.
    Jääskeläinen I; Mönkkönen J; Urtti A
    Biochim Biophys Acta; 1994 Oct; 1195(1):115-23. PubMed ID: 7918553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of oligonucleotides with cationic lipids: the relationship between electrostatics, hydration and state of aggregation.
    Meidan VM; Cohen JS; Amariglio N; Hirsch-Lerner D; Barenholz Y
    Biochim Biophys Acta; 2000 Apr; 1464(2):251-61. PubMed ID: 10727612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages.
    De Rosa G; De Stefano D; Laguardia V; Arpicco S; Simeon V; Carnuccio R; Fattal E
    Eur J Pharm Biopharm; 2008 Sep; 70(1):7-18. PubMed ID: 18482831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.